Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Alexion Pharmaceuticals (ALXN)

Add to Watchlists
Create an Alert
156.50 +4.27  +2.80% NASDAQ Apr 24, 2:25PM BATS Real time Currency in USD

Alexion Pharmaceuticals Retained Earnings (Quarterly):

379.10M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Alexion Pharmaceuticals Retained Earnings (Quarterly) Chart

Export Data
Save Image

Alexion Pharmaceuticals Historical Retained Earnings (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 379.10M
Sept. 30, 2013 398.09M
June 30, 2013 304.30M
March 31, 2013 208.42M
Dec. 31, 2012 126.20M
Sept. 30, 2012 45.23M
June 30, 2012 -46.95M
March 31, 2012 -83.21M
Dec. 31, 2011 -128.62M
Sept. 30, 2011 -176.79M
June 30, 2011 -242.36M
March 31, 2011 -277.10M
Dec. 31, 2010 -303.93M
Sept. 30, 2010 -330.38M
June 30, 2010 -358.26M
March 31, 2010 -380.03M
Dec. 31, 2009 -400.96M
Sept. 30, 2009 -638.09M
June 30, 2009 -664.82M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Oct. 31, 2005 Upgrade
July 31, 2005 Upgrade
April 30, 2005 Upgrade
Jan. 31, 2005 Upgrade
Oct. 31, 2004 Upgrade
July 31, 2004 Upgrade
April 30, 2004 Upgrade
Jan. 31, 2004 Upgrade
Oct. 31, 2003 Upgrade
July 31, 2003 Upgrade
April 30, 2003 Upgrade
Jan. 31, 2003 Upgrade
Oct. 31, 2002 Upgrade
July 31, 2002 Upgrade
April 30, 2002 Upgrade
Jan. 31, 2002 Upgrade
Oct. 31, 2001 Upgrade
July 31, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Retained Earnings

The net income that remains after paying dividends. It is reported on the balance sheet as the cumulative sum of each year's retained earnings over the life of the business. Retained earnings can be used to pay debt and future dividends, or can be reinvested into business activities.

The "retained" refers to the earnings after paying out dividends. Companies with increasing retained earnings is good, because it means the company is staying consistently profitable. If a company has a yearly loss, this number is subtracted from retained earnings.

If a company's annual net income was 5 million, paid out 3 million in dividends, and had a retained earnings of 9 million, retained earnings at the end of 2012 would be 11 million (5-3+9). Similarly if next year the company paid no dividends but had a yearly net income loss of 5 million, retained earnings would be 6 million (11-5).
Learn More

Get data for
Advertisement

ALXN Retained Earnings (Quarterly) Benchmarks

Companies
Biomarin Pharmaceutical -715.80M
Regeneron Pharmaceuticals -92.69M
Amgen -7.634B

ALXN Retained Earnings (Quarterly) Range, Past 5 Years

Minimum -664.82M Jun 2009
Maximum 398.09M Sep 2013
Average -135.27M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.